Kancera provides operational update and announces issue of shares according to agreement with Global Corporate Finance
Kancera AB (Nasdaq First North: CAN) today announced that two patent applications within the fractalkine project are now entering international phase and that the agreement with US Global Corporate Finance (GCF) has been utilized for a second new issue of 5,000,000 shares.
Read More